Nabriva Therapeutics plc Quarterly Common Stock, Shares Authorized from Q4 2015 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Nabriva Therapeutics plc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2015 to Q2 2023.
  • Nabriva Therapeutics plc Common Stock, Shares Authorized for the quarter ending June 30, 2023 was 12M shares, a 96% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 12M -288M -96% Jun 30, 2023 10-Q 2023-10-19
Q1 2023 12M -288M -96% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 12M 0 0% Dec 31, 2022 10-Q 2023-10-19
Q3 2022 12M -88M -88% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 300M +200M +200% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 300M +200M +200% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 12M -88M -88% Dec 31, 2021 10-K 2023-04-17
Q3 2021 100M -900M -90% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 100M -900M -90% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 100M -900M -90% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 100M 0 0% Dec 31, 2020 10-K 2022-03-29
Q3 2020 1B 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 1B 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 1B 0 0% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 100M -900M -90% Dec 31, 2019 10-K 2021-03-11
Q3 2019 1B 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 1B 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 1B 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 1B 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 1B Sep 30, 2018 10-Q 2018-11-06
Q2 2018 1B Jun 30, 2018 10-Q 2018-08-09
Q1 2018 1B +999M +71926% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 1B +999M +71854% Dec 31, 2017 10-Q 2018-11-06
Q1 2017 1.39M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 1.39M +477K +52.2% Dec 31, 2016 10-Q 2017-05-10
Q4 2015 913K Dec 31, 2015 10-K 2017-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.